
UnitedHealth Group (UNH) Stock Forecast & Price Target
UnitedHealth Group (UNH) Analyst Ratings
Bulls say
UnitedHealth Group is a strong performer in the private health insurance industry due to its massive scale, diverse business segments, and strong balance sheet with significant free cash flow. With the recovery of its Optum Health segment and potential for margin growth, the company has strong potential for earnings growth in the future. Additionally, its investments in AI and technology further enhance its competitive advantage. However, risks to its outlook include exposure to government contracts, regulatory changes, and competition. Overall, a Buy rating is recommended with a price target of $395 based on the company's current and potential future earnings.
Bears say
UnitedHealth Group is a leading player in the medical insurance industry, with diversified assets and earnings across various lines of business. However, there are downside risks to their future growth, including potential reimbursement reductions and increased competition in the Medicare Advantage market, as well as regulatory risks for their pharmacy benefits management operations. As a result, the outlook for UnitedHealth Group's stock is negative, with concerns about potential margin pressures and potential impact on earnings growth.
This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.
UnitedHealth Group (UNH) Analyst Forecast & Price Prediction
Start investing in UnitedHealth Group (UNH)
Order type
Buy in
Order amount
Est. shares
0 shares